Details of the Drug

General Information of Drug (ID: DMT584A)

Drug Name

ALN-VEG01

Synonyms

RNAi therapeutics (ocular disease), Alnylam; VEGF-silencing siRNAs, Alnylam; Vascular endothelial growth factor gene-silencing siRNAs, Alnylam; RNAi therapeutics (ocular disease), Alnylam/Merck; VEGF-silencing siRNAs, Alnylam/Merck; Vascular endothelial growth factor-silencing siRNAs, Alnylam/Merck

Indication

Disease Entry	ICD 11	Status	REF
Macular degeneration	9B78.3	Terminated	[1]

Drug Type

siRNA drug

Cross-matching ID

TTD ID: D05ITS

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
VEGF messenger RNA (VEGF mRNA)	TT3LJ9K	VEGFA_HUMAN	Not Available	[2]

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025250)
2	Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals.